# BRD4 degrader payloads

Source: https://onco.cc/terms/brd4-degrader-payloads/  
OnCo record `brd4-degrader-payloads` (Term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

These payloads cause the cell to remove a protein that helps control gene activity. Antibody-linked versions have been tested in cancer cells and mice.

## Summary

BRD4-directed heterobifunctional degraders recruit the cell's protein-disposal machinery rather than simply occupying an enzyme. Primary work demonstrated antigen-dependent BRD4 depletion and antitumor activity with degrader-antibody conjugates in mouse xenografts. This evidence supports antibody-mediated delivery of a degrader but does not establish that every intracellular protein can be reached or that a clinical therapeutic window follows from protein removal.

## Fields

- Kind: Term
- Last checked: 2026-11-08
- Also known as: BET degrader antibody payloads; antibody-PROTAC payloads

## Sources

- Dragovich et al., antibody delivery of BRD4 degraders, part 2 (2021): https://doi.org/10.1021/acs.jmedchem.0c01846

## Connected records

- technologies: [Antibody-drug conjugate (ADC)](https://onco.cc/technologies/adc/), [Degrader-antibody conjugate (DAC)](https://onco.cc/technologies/degrader-antibody-conjugate/), [PROTACs & molecular glues (targeted protein degradation)](https://onco.cc/technologies/protac-degrader/)
- targets: [BRD4](https://onco.cc/targets/brd4/)
- terms: [Next-generation antibody-conjugate payloads](https://onco.cc/terms/next-generation-adc-payloads/), [Payload (ADC)](https://onco.cc/terms/payload/)

---
JSON: https://onco.cc/api/v1/entities/brd4-degrader-payloads.json